Abstract
Objectives Our aim was to derive, based on the SWEDEHEART registry, and validate, using the Western Denmark Heart registry, a patient-oriented risk score, the SweDen score, which could calculate the risk of 1-year mortality following a myocardial infarction (MI).
Methods The factors included in the SweDen score were age, sex, smoking, diabetes, heart failure, and statin use. These were chosen a priori by the SWEDEHEART steering group based on the premise that the factors were information known by the patients themselves. The score was evaluated using various statistical methods such as time-dependent receiver operating characteristics curves of the linear predictor, area under the curve metrics, Kaplan-Meier survivor curves, and the calibration slope.
Results The area under the curve values were 0.81 in the derivation data and 0.76 in the validation data. The Kaplan-Meier curves showed similar patient profiles across datasets. The calibration slope was 1.03 (95% CI 0.99-1.08) in the validation data using the linear predictor from the derivation data.
Conclusions The SweDen risk score is a novel tool created for patient use. The risk score calculator will be available online and presents mortality risk on a colour scale to simplify interpretation and to avoid exact life span expectancies. It provides a validated patient-oriented risk score predicting the risk of death at 1 year after suffering a MI, which visualizes the benefit of statin use and smoking cessation in a simple way.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Swedish Research council and the Swedish HeartLung foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics committee in Lund, 2015, 297-approval code. The data is from the SWEDEHEART registry and individuals are automatically included in registries unless they opt out.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The funding comes from the Swedish Research council and the Swedish HeartLung foundation
philippe.wagner{at}regionvastmanland.se,
michael.maeng{at}clin.au.dk,
joakim.alfredsson{at}liu.se,
tomas.jernberg{at}ki.se,
pelle.Johansson{at}hjartlung.se
peter.vasko{at}rikssvikt.se,
Data Availability
Researchers interested in further analyses of the data can contact the authors.
